Evelo Biosciences' Series B Round

Evelo Biosciences raised a round of funding on January 18, 2017.

Evelo Biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines – monoclonal microbials. Monoclonal microbials are orally delivered …

Articles about Evelo Biosciences' Series B Round: